|
|
Home
The Word Brain
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Inflammatory Bowel Diseases |
|
Free Subscription
2 Am J Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Inflammatory Bowel Diseases is free of charge.
Primer: Understanding Medicare for Advanced Therapies for Inflammatory Bowel
Disease.
Am J Gastroenterol. 2026 May 5. doi: 10.14309/ajg.0000000000004042.
PubMed
Improvement in Health-Related Quality of Life in Patients With Moderate to Severe
Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B
SEQUENCE Study.
Am J Gastroenterol. 2026 May 5. doi: 10.14309/ajg.0000000000004044.
PubMed
Abstract available
Clin Res Hepatol Gastroenterol
Beyond pharmacotherapy in IBD: feasibility and patient-reported benefits of a
six-week multimodal rehabilitation pilot.
Clin Res Hepatol Gastroenterol. 2026;50:102818.
PubMed
Abstract available
Comment on "Can peripheral blood eosinophils predict primary non-response to
Infliximab therapy in pediatric Crohn's disease?".
Clin Res Hepatol Gastroenterol. 2026 May 2:102838.
PubMed
Correction: Self-Efficacy as a Mediator Between Caregiver Burden, Health
Literacy, and Contribution to Self-Care in Inflammatory Bowel Disease.
Dig Dis Sci. 2026 May 8. doi: 10.1007/s10620-026-09942.
PubMed
A Bloody Mimic of Crohn's Disease: Primary Intestinal EBV-Positive NK/T-Cell
Lymphoma.
Dig Dis Sci. 2026 May 7. doi: 10.1007/s10620-026-09900.
PubMed
Management of Patients with Ulcerative Proctitis: A Global Survey.
Dig Dis Sci. 2026;71:1416-1424.
PubMed
Abstract available
Outcomes of Hospitalized Patients with Severe UC from 1997 to 2021 in a Large
Regional Healthcare System in the US.
Dig Dis Sci. 2026;71:1425-1433.
PubMed
Abstract available
Evaluation of Obesity as an Independent Risk Factor for Colorectal Dysplasia
Development in Inflammatory Bowel Disease: A Matched Case-Control Study.
Dig Dis Sci. 2026 May 5. doi: 10.1007/s10620-026-09951.
PubMed
Abstract available
Advancing the Efficacy and Safety of Advanced Therapies in Older Adults with
Inflammatory Bowel Disease.
Dig Dis Sci. 2026 May 5. doi: 10.1007/s10620-026-09947.
PubMed
Comparative Outcomes of Primary Sclerosing Cholangitis With and Without Comorbid
Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Dig Dis Sci. 2026 May 5. doi: 10.1007/s10620-026-09964.
PubMed
Abstract available
Strength of Association: How Useful Is Handgrip Strength as a Functional
Biomarker in Patients with Inflammatory Bowel Disease?
Dig Dis Sci. 2026 May 6. doi: 10.1007/s10620-026-09959.
PubMed
Letter to the editor regarding 'Correlation between infliximab trough levels and
postoperative endoscopic recurrence in patients with Crohn's disease'.
Eur J Gastroenterol Hepatol. 2026;38:779.
PubMed
Appendicectomy in active ulcerative colitis: is the evidence strong enough to
support clinical recommendation? A critical appraisal.
Eur J Gastroenterol Hepatol. 2026;38:777-778.
PubMed
Comment on 'Home-based transcutaneous electrical acupuncture-point stimulation
for depressive symptoms in inflammatory bowel disease: a randomized feasibility
study'.
Eur J Gastroenterol Hepatol. 2026;38:774-775.
PubMed
Prevalence, risk factors, and clinical outcomes of extraintestinal manifestations
in inflammatory bowel disease: a population-based study in china.
Eur J Gastroenterol Hepatol. 2026 Apr 6. doi: 10.1097/MEG.0000000000003197.
PubMed
Abstract available
Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in
biologic-naive patients with noncomplicated or complex Crohn's disease: results
from the EVOLVE Expansion study.
Eur J Gastroenterol Hepatol. 2026 Apr 6. doi: 10.1097/MEG.0000000000003193.
PubMed
Abstract available
Recommendations for the Evaluation and Management of Inflammatory Bowel Disease
with Irritable Bowel Syndrome-Like Symptoms: A Joint Rome Foundation and
International Organization for the Study of IBD (IOIBD) Consensus.
Gastroenterology. 2026 Apr 29:S0016-5085(26)06758.
PubMed
Abstract available
Multi-omics-based machine learning model predicts response and guides treatment
in Crohn disease: a case study in nutritional therapy.
Inflamm Bowel Dis. 2026 May 4:izag060. doi: 10.1093.
PubMed
Abstract available
Early Intestinal Ultrasound Assessment Predicts Therapy Response: An Easy Tool
for Clinical Decision-Making.
Inflamm Bowel Dis. 2026;32:938-944.
PubMed
Abstract available
Systematic review and meta-analysis of childhood exposure to antibiotics and the
subsequent risk of IBD.
Inflamm Bowel Dis. 2026;32:990-997.
PubMed
Abstract available
Selective IL-23 inhibitors in ulcerative colitis: current evidence and
perspectives for multimodal personalized treatment: a narrative review.
J Gastroenterol. 2026 May 2. doi: 10.1007/s00535-026-02429.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
